Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 25, 2020 - Issue 2
Submit an article Journal homepage
465
Views
10
CrossRef citations to date
0
Altmetric
Review

Emerging therapies in β-thalassemia: toward a new era in management

Rayan Bou-FakhredinDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, LebanonView further author information
,
Rami TabbikhaDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, LebanonView further author information
,
Hisham DaadaaDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, LebanonView further author information
&
Ali T. TaherDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, LebanonCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8515-2238View further author information
ORCID Icon
Pages 113-122 | Received 23 Feb 2020, Accepted 02 Apr 2020, Published online: 15 Apr 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ali T. Taher, Rayan Bou-Fakhredin, Antonis Kattamis, Vip Viprakasit & Maria Domenica Cappellini. (2021) Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies. Expert Review of Hematology 14:10, pages 897-909.
Read now

Articles from other publishers (9)

Peter Hokland, Shahina Daar, Wael Khair, Sujit Sheth, Ali T. Taher, Lorenza Torti, Chattree Hantaweepant & Deborah Rund. (2023) Thalassaemia—A global view. British Journal of Haematology 201:2, pages 199-214.
Crossref
Rayan Bou-Fakhredin, Kevin H.M. Kuo & Ali T. Taher. (2023) Emerging Therapies in β-Thalassemia. Hematology/Oncology Clinics of North America 37:2, pages 449-462.
Crossref
Marta Ferraresi, Daniele Lello Panzieri, Simona Leoni, Maria Domenica Cappellini, Antonis Kattamis & Irene Motta. (2023) Therapeutic perspective for children and young adults living with thalassemia and sickle cell disease. European Journal of Pediatrics 182:6, pages 2509-2519.
Crossref
Mihai-Octavian Dan, Bianca-Ioana Gutu, Emilia Severin & Vlad-George Tanase. (2023) Innovative and Needs-led research on β-thalassemia treatment methods. Frontiers in Hematology 1.
Crossref
Pharit Kamsri, Auradee Punkvang, Somjintana Taveepanich, Sombat Ketrat, Patchreenart Saparpakorn, Supa Hannongbua, Khomson Suttisintong, Kanjana Pangjit & Pornpan Pungpo. (2022) In silico multiscale drug design to discover key structural features of potential JAK2 inhibitors . Future Medicinal Chemistry 14:18, pages 1297-1308.
Crossref
Laura Grech, Karen Borg & Joseph Borg. (2021) Novel therapies in β‐thalassaemia. British Journal of Clinical Pharmacology 88:6, pages 2509-2524.
Crossref
Khaled M. Musallam, Rayan Bou‐Fakhredin, Maria Domenica Cappellini & Ali T. Taher. (2021) 2021 update on clinical trials in β‐thalassemia. American Journal of Hematology 96:11, pages 1518-1531.
Crossref
Ujjwal Madan, Himani Bhasin, Pooja Dewan & Jyotsna Madan. (2021) Improving Ineffective Erythropoiesis in Thalassemia: A Hope on the Horizon. Cureus.
Crossref
Achille Iolascon, Stefano Rivella, Nicholas P. Anagnou, Clara Camaschella, Dorine Swinkels, Martina U. Muckenthaler, Graça Porto, Wilma Barcellini, Immacolata Andolfo, Antonio M. Risitano, Antonis Kattamis, Maria Domenica Cappellini, Ali T. Taher, Lucia De Franceschi, David Rees, Roberta Russo, Hannah Tamary, Reinhard Stauder & Domenico Girelli. (2021) The EHA Research Roadmap: Anemias. HemaSphere 5:7, pages e607.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.